|
CEP290 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.61790000788409E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.90300000038712E-07 |
| Normal-vs-Stage2 |
3.460200E-02 |
| Normal-vs-Stage3 |
3.281100E-03 |
| Normal-vs-Stage4 |
6.957700E-03 |
| Stage1-vs-Stage2 |
9.506600E-01 |
| Stage1-vs-Stage3 |
6.258600E-01 |
| Stage1-vs-Stage4 |
7.778200E-01 |
| Stage2-vs-Stage3 |
7.289000E-01 |
| Stage2-vs-Stage4 |
8.107400E-01 |
| Stage3-vs-Stage4 |
9.728800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.34370000973661E-09 |
| Normal-vs-AfricanAmerican |
6.4969999999942E-05 |
| Normal-vs-Asian |
2.129000E-01 |
| Caucasian-vs-AfricanAmerican |
8.019000E-01 |
| Caucasian-vs-Asian |
8.753600E-01 |
| AfricanAmerican-vs-Asian |
8.219600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.74569999566998E-08 |
| Normal-vs-Female |
1.80130000027034E-07 |
| Male-vs-Female |
5.022400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.840200E-04 |
| Normal-vs-Extreme_Weight |
5.86320000000029E-05 |
| Normal-vs-Obese |
4.18420000003472E-06 |
| Normal-vs-Extreme_Obese |
5.659700E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.375800E-01 |
| Normal_Weight-vs-Obese |
6.091200E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.860200E-01 |
| Extreme_Weight-vs-Obese |
2.622400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.164600E-01 |
| Obese-vs-Extreme_Obese |
2.630200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.422700E-04 |
| Normal-vs-Age(41-60Yrs) |
7.69389996158054E-10 |
| Normal-vs-Age(61-80Yrs) |
3.9182000000082E-06 |
| Normal-vs-Age(81-100Yrs) |
2.438000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.632010E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.792400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.608150E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.701700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.957900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.586000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.50177697739218E-12 |
| Normal-VS-Type2 PRCC |
6.189700E-02 |
| Normal-VS-KIRP CIMP |
1.174050E-02 |
| Normal-VS-Unclassified PRCC |
1.246890E-04 |
| Type1 PRCC-VS-Type2 PRCC |
2.14840000012373E-07 |
| Type1 PRCC-VS-KIRP CIMP |
2.392600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.496000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.208400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.024000E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
4.730400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.216400E-03 |
| Normal-vs-N1 |
1.023340E-03 |
| Normal-vs-N2 |
3.283600E-02 |
| N0-vs-N1 |
7.172000E-02 |
| N0-vs-N2 |
7.368800E-01 |
| N1-vs-N2 |
6.229400E-01 |
|
|
